The present study aimed to summarize the characteristics of the insulin dosage ratio in patients with T2DM with different C-peptide levels when the blood glucose level reaches the target, and analyzed the relevant influencing factors, in order to provide a clinical basis for the initial dosage setting of insulin pumps for patients with T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.